To examine the efficacy of the NICE program, we screened a library of 79 protein kinase inhibitors and validated the effect of CaMKII, JAK-3 and IκB IKK inhibitors on mammosphere formation and EMT of breast cancer cells, which suggest potential target for treatment of breast cancer via modulating the development and growth of CSC. This evidence concerns the gene CAMK2G and breast cancer.